Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, January 3, 2022
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
Sun, January 2, 2022
[ Sun, Jan 02nd 2022
] - WOPRAI
[ Sun, Jan 02nd 2022
] - WOPRAI
Fri, December 31, 2021
[ Fri, Dec 31st 2021
] - WOPRAI
[ Fri, Dec 31st 2021
] - WOPRAI
[ Fri, Dec 31st 2021
] - WOPRAI
[ Fri, Dec 31st 2021
] - WOPRAI
[ Fri, Dec 31st 2021
] - WOPRAI
[ Fri, Dec 31st 2021
] - WOPRAI
Roanna Ruiz Maintained (XERS) at Buy with Increased Target to $8 on, Dec 31st, 2021
Roanna Ruiz of SVB Leerink, Maintained "Xeris Biopharma Holdings, Inc." (XERS) at Buy with Increased Target from $6 to $8 on, Dec 31st, 2021.
Roanna, nor any peers, have made any analyst calls on XERS in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30